Gluomni-M2

Gluomni-M2 by EMK Omni Pharma is a prescription-based Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP formulation used for doctor-supervised type 2 diabetes management, blood sugar control, and long-term glycaemic support. Each uncoated bilayered tablet contains Glimepiride IP 2 mg and Metformin Hydrochloride IP 500 mg as prolonged release. Gluomni-M2 is commonly prescribed by healthcare professionals for patients who require support in managing high blood glucose levels, insulin resistance, glucose imbalance, and type 2 diabetes care. Gluomni-M2 Glimepiride 2 mg and Metformin 500 mg Tablets by EMK Omni Pharma are designed for physician-guided diabetes treatment where dual-action blood sugar management and sustained glucose control are required. This medicine should be used only as advised by a registered medical practitioner.

Gluomni-M2 may be prescribed by doctors for patients who require support in managing type 2 diabetes, high blood sugar levels, insulin resistance, glucose imbalance, and long-term glycaemic control. It may be used as part of a complete physician-guided diabetes care plan that includes medication, diet management, exercise, lifestyle correction, and regular blood sugar monitoring. Gluomni-M2 by EMK Omni Pharma is suitable for doctor-supervised treatment where blood glucose control, diabetes management, and sustained metabolic support are required. Patients should not self-medicate, change the dosage, stop the medicine, or combine it with other diabetes medicines without consulting their doctor.